Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
Bullous/Blistering Skin Disorders
How do you manage pemphigus patients who have persistent disease and circulating autoantibodies despite two full courses of rituximab?
Related Questions
Are there patients with pemphigus whom you plan to give additional doses of rituximab even if they are in complete remission at six months from their initial dose?
What treatment combination approach would you recommend for mucous membrane pemphigoid?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
How do you manage pemphigus vulgaris in patients who lack insurance coverage for biologics and routine laboratory monitoring?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
What is your diagnostic approach to mild, chronic eosinophilia with AEC <1500?
How do you bill cosmetic follow-up appointments?
What circumstances would drive you to consider using an oral IL-23 inhibitor over parenteral options for the management of psoriasis and/or psoriatic arthritis?
Do you avoid progestin only contraceptives and IUDs in patients with acne due to their androgenic properties?
What is the role of hair transplantation for scarring alopecias like lichen planopilaris?
